These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25374012)

  • 1. Emerging therapy options in heparin-induced thrombocytopenia.
    Chaudhary RK; Khanal N; Giri S; Pathak R; Bhatt VR
    Cardiovasc Hematol Agents Med Chem; 2014; 12(1):50-8. PubMed ID: 25374012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia.
    Tran PN; Tran MH
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):201-209. PubMed ID: 28301915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Oral Anticoagulants for the Management of Heparin Induced Thrombocytopenia: A Focused Literature Review.
    Dhakal P; Pathak R; Giri S; Murthy GS; Bhatt VR
    Cardiovasc Hematol Agents Med Chem; 2015; 13(2):87-91. PubMed ID: 26695419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment.
    Hvas AM; Favaloro EJ; Hellfritzsch M
    Expert Rev Hematol; 2021 Apr; 14(4):335-346. PubMed ID: 33736552
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
    J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.
    Krauel K; Fürll B; Warkentin TE; Weitschies W; Kohlmann T; Sheppard JI; Greinacher A
    J Thromb Haemost; 2008 Dec; 6(12):2160-7. PubMed ID: 18983520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
    Krauel K; Hackbarth C; Fürll B; Greinacher A
    Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role of Direct Oral Anticoagulants in the Management of Heparin-induced Thrombocytopenia.
    Barlow A; Barlow B; Reinaker T; Harris J
    Pharmacotherapy; 2019 Aug; 39(8):837-853. PubMed ID: 31233222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Kropff S; Müller MM; Lindhoff-Last E
    Thromb Res; 2014 Jul; 134(1):29-35. PubMed ID: 24703295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin-induced thrombocytopenia].
    Thiele T; Althaus K; Greinacher A
    Internist (Berl); 2010 Sep; 51(9):1127-32, 1134-5. PubMed ID: 20694716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Linkins LA; Dans AL; Moores LK; Bona R; Davidson BL; Schulman S; Crowther M
    Chest; 2012 Feb; 141(2 Suppl):e495S-e530S. PubMed ID: 22315270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux as a treatment option for heparin-induced thrombocytopenia.
    Papadopoulos S; Flynn JD; Lewis DA
    Pharmacotherapy; 2007 Jun; 27(6):921-6. PubMed ID: 17542773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options in heparin-induced thrombocytopenia.
    Hook KM; Abrams CS
    Curr Opin Hematol; 2010 Sep; 17(5):424-31. PubMed ID: 20601872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of heparin-induced thrombocytopenia].
    Aouizerate P; Guizard M
    Therapie; 2002; 57(6):577-88. PubMed ID: 12666266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia.
    Davis KA; Davis DO
    Eur J Haematol; 2017 Oct; 99(4):332-335. PubMed ID: 28672052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia: treatment options and special considerations.
    Dager WE; Dougherty JA; Nguyen PH; Militello MA; Smythe MA
    Pharmacotherapy; 2007 Apr; 27(4):564-87. PubMed ID: 17381384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia: pathophysiology and new treatment options.
    Harenberg J; Jörg I; Fenyvesi T
    Pathophysiol Haemost Thromb; 2002; 32(5-6):289-94. PubMed ID: 13679659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The approach to heparin-induced thrombocytopenia.
    Linkins LA; Warkentin TE
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.